Why the study?
Does additional adjuvant systemic therapy improve overall survival and progression-free survival compared to definitive local therapy alone in patients with head and neck synovial sarcomas?
Does additional adjuvant systemic therapy improve overall survival and progression-free survival compared to definitive local therapy alone in patients with head and neck synovial sarcomas?
In patients with head and neck synovial sarcomas, tumor size ≥ 5 cm and primary presentation in the soft tissues of the neck are predictive of worse progression-free survival, while adjuvant systemic therapy did not significantly improve survival compared to local therapy alone.
Answers are grounded in this paper and cite their sources.
May guide surveillance intensity in head and neck synovial sarcoma; leaves open adjuvant therapy benefit in high-risk subsets.
Background . The prognosis and clinical characteristics of head and neck synovial sarcomas (HNSS) are unclear. Herein, we present an update using a cohort of patients treated at our institution. Methods . We performed a retrospective chart review of 44 patients diagnosed with primary HNSS between March 1990 and June 2012. Overall survival (OS) and progression-free survival (PFS) curves were estimated and hazard ratios (HRs) were calculated. Results . The entire cohort’s median PFS was 4.6 years, and 20 of the 44 (45%) patients developed either local or distant recurrence. Tumor size ≥ 5 cm (p=0.008, HR = 4.69; 95% CI = 1.34–16.38) and a primary presentation in the soft tissues of the neck (p=0.04, HR = 2.41; 95% CI = 1.003–5.82) were associated with significantly worse PFS. The OS and PFS of patients who received definitive local therapy versus those who received additional adjuvant systemic therapy did not differ significantly. Conclusion . Despite the treatment challenges associated with HNSS, our cohort of patients had a better prognosis than one might expect in this unfavorable anatomical location. Our findings suggest that tumor size and site are predictive of PFS and that wide surgical excision is of vital importance, since traditional cytotoxic chemotherapy has limited efficacy at this site.
No takes yet. Share an insight, caveat, or question.
Gopalakrishnan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: